[go: up one dir, main page]

AU2003248355A1 - Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist - Google Patents

Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist

Info

Publication number
AU2003248355A1
AU2003248355A1 AU2003248355A AU2003248355A AU2003248355A1 AU 2003248355 A1 AU2003248355 A1 AU 2003248355A1 AU 2003248355 A AU2003248355 A AU 2003248355A AU 2003248355 A AU2003248355 A AU 2003248355A AU 2003248355 A1 AU2003248355 A1 AU 2003248355A1
Authority
AU
Australia
Prior art keywords
pyridyl
beta
salt
receptor agonist
adrenergic receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003248355A
Inventor
Joseph Francis Krzyzaniak
Jennifer Anne Lafontaine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of AU2003248355A1 publication Critical patent/AU2003248355A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003248355A 2002-02-27 2003-02-17 Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist Abandoned AU2003248355A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36024802P 2002-02-27 2002-02-27
US60/360,248 2002-02-27
PCT/IB2003/000575 WO2003072571A1 (en) 2002-02-27 2003-02-17 Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist

Publications (1)

Publication Number Publication Date
AU2003248355A1 true AU2003248355A1 (en) 2003-09-09

Family

ID=27766205

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003248355A Abandoned AU2003248355A1 (en) 2002-02-27 2003-02-17 Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist

Country Status (8)

Country Link
AR (1) AR038603A1 (en)
AU (1) AU2003248355A1 (en)
GT (1) GT200300044A (en)
PA (1) PA8567601A1 (en)
PE (1) PE20030900A1 (en)
TW (1) TW200305414A (en)
UY (1) UY27678A1 (en)
WO (1) WO2003072571A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
CZ20031012A3 (en) * 2000-10-20 2004-04-14 Pfizer Products Inc. Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists

Also Published As

Publication number Publication date
UY27678A1 (en) 2003-10-31
PE20030900A1 (en) 2003-10-25
TW200305414A (en) 2003-11-01
WO2003072571A1 (en) 2003-09-04
PA8567601A1 (en) 2003-12-10
AR038603A1 (en) 2005-01-19
GT200300044A (en) 2003-09-22

Similar Documents

Publication Publication Date Title
AU2003302919A1 (en) Pyridine derivatives as jnk inhibitors and their use
AU2003290700A1 (en) Farnesoid x receptor agonists
AU2002210782A1 (en) Amide derivatives as nmda receptor antagonists
AU2003260345A1 (en) 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
AU2003228485A1 (en) Farnesoid x-activated receptor agonists
HUS1400047I1 (en) Quinoline derivatives and their use as mycobacterial inhibitors
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003280188A1 (en) Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
AU2003226927A1 (en) Novel carboxamide compounds for use in mch receptor related disorders
AU2003288640A1 (en) Benzamide inhibitors of the p2x7 receptor
AU2003241833A1 (en) Beta-ALANINE DERIVATIVE AND USE THEREOF
AU2003251705A1 (en) Idol derivatives as new thyroid receptor agonist ligands and methods
AU2003202116A1 (en) Nicotinamide derivatives useful as pde4 inhibitors
AU2003275838A1 (en) Pyrrolidin-2-on derivatives as ep4 receptor agonists
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2003207023A1 (en) Piperidine derivatives and their use as antagonists of tachykinins
IL176515A0 (en) 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
AU2003218660A8 (en) Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
AU2003252314A1 (en) 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof
AUPQ570100A0 (en) Beta-alanine derivatives and their use as receptor antagonists
AU2003268464A1 (en) INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003248355A1 (en) Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase